Kidney Cancers: Clinical Trials

15 trials for Kidney Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 3 active not recruiting, 3 completed, 1 not yet recruiting. 5 Not applicable, 3 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Active not recruiting 2, Completed 1, Recruiting 1, Withdrawn 1
Phase 23Recruiting 2, Completed 1
Phase 12Recruiting 2
Early Phase 11Recruiting 1
Phase 31Completed 1

Follow Kidney Cancers: new trials by email Literature Review of Kidney Cancers trials Research Report on Kidney Cancers

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Medical Reading, AI assisted Medical reading - Kidney Cancers, Prostate Cancer
Not yet recruitingAristotle University Of Thessaloniki502026-10-152026-10-22
Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
5-Aminolevulinic acid Hydrochloride (Gliolan®) - Kidney Cancers
Phase 2RecruitingHenry Ford Health System102026-09-152026-09-18
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
NEO-811 - Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma
Phase 1RecruitingNeomorph, Inc302025-12-192026-10-05
Targeted Abdominal CT in Conjunction With Lung Cancer Screening
Lung Cancer Screening Invitation Intervention, Abdominal scan intervention - Renal Cell Carcinoma (Kidney Cancer), Kidney Cancers
Not applicableRecruitingUniversity of Cambridge62722025-11-112025-12-19
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
[212Pb]VMT-alpha-NET, [203Pb]VMT-alpha-NET, 68Ga-DOTATATE - Sinonasal Neuroendocrine Carcinoma, Nasopharyngeal Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)1202025-08-192026-10-06
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Comprehensive multimodal prehabilitation (CMMP) - Hepatopancreaticobiliary (HPB) Malignancy, Ovarian Cancer (OvCa)
Phase 2RecruitingThe Methodist Hospital Research Institute1482025-08-142026-03-12
Clinical Application of CAIX-Targeted PET Imaging in Tumors
Each patient will undergo 68Ga/18F-CAIX-LT-BCH PET/CT imaging, with an administered radioactive dose of approximately 0.05-0.1 mCi/kg. - Kidney Cancers
Early Phase 1RecruitingPeking University Cancer Hospital & Institute32025-03-012026-05-15
Prehabilitation Prior to Surgery for Kidney Tumors
Prehabilitation - Renal Cancer, Renal Cell Cancer
Not applicableActive not recruitingHerlev and Gentofte Hospital602025-01-212026-09-02
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer
Phase 2CompletedUniversity of Southern California1202025-01-162026-05-06
Renal Tumour Imaging Using MRI
MRI - Renal Cancer, MRI
Not applicableActive not recruitingUniversity College, London302024-11-202025-09-15
Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
Blood sample - Kidney Cancers, Bladder Cancer
RecruitingUniversity Hospital, Strasbourg, France1002024-09-022026-09-15
Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study
mpMRI - Kidney Cancers
Not applicableCompletedUniversity of Zurich92023-08-022026-10-28
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
VasoClip®, WeckClip® - Prostate Cancer (Adenocarcinoma), Kidney Cancers
Phase 3CompletedIncheon St.Mary's Hospital402020-05-072026-02-17
Evaluation of 68Ga-PSMA PET-CT in the Initial Staging of Advanced Renal Cell Carcinomas - A Prospective, Multicentre, Open-label Study
68Ga-PSMA PET-CT scan - Kidney Cancers
Not applicableWithdrawnAssistance Publique Hopitaux De Marseille2020-01-012026-06-03
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
Laparoscopic nephrectomy for kidney cancer, Open nephrectomy for kidney cancer - Hydrocele, Hydrocele of Tunica Vaginalis
Active not recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's400002002-04-012026-09-14

Narrower conditions

Kidney Neoplasms (15)  ·  Carcinoma, Renal Cell (4)  ·  Prostatic Neoplasms (4)  ·  Urinary Bladder Neoplasms (3)  ·  Adenocarcinoma (2)  ·  Aortic Aneurysm, Abdominal (1)  ·  Clear-cell metastatic renal cell carcinoma (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Neoplasms (1)  ·  Nephrolithiasis (1)  ·  Ovarian Neoplasms (1)  ·  Paraganglioma (1)

Broader conditions

Female Urogenital Diseases (15)  ·  Female Urogenital Diseases and Pregnancy Complications (15)  ·  Kidney Diseases (15)  ·  Male Urogenital Diseases (15)  ·  Neoplasms by Site (15)  ·  Urogenital Diseases (15)  ·  Urogenital Neoplasms (15)  ·  Urologic Diseases (15)  ·  Urologic Neoplasms (15)  ·  Neoplasms (14)  ·  Carcinoma (7)  ·  Neoplasms by Histologic Type (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Genital Diseases (6)  ·  Genital Diseases, Male (5)

Interventions

Aminolevulinic Acid (1)  ·  Blood Specimen Collection (1)  ·  Exercise (1)  ·  Geriatric Assessment (1)  ·  Multiparametric Magnetic Resonance Imaging (1)  ·  Preoperative Exercise (1)  ·  gallium Ga 68 dotatate (1)

Sponsors

Aristotle University Of Thessaloniki (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Henry Ford Health System (1)  ·  Herlev and Gentofte Hospital (1)  ·  Incheon St.Mary's Hospital (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  National Cancer Institute (NCI) (1)  ·  Neomorph, Inc (1)  ·  Peking University Cancer Hospital & Institute (1)  ·  The Methodist Hospital Research Institute (1)  ·  University College, London (1)  ·  University Hospital, Strasbourg, France (1)  ·  University of Cambridge (1)  ·  University of Southern California (1)  ·  University of Zurich (1)

Countries

United States (5)  ·  United Kingdom (2)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Antonis Billis, PhD (1)  ·  Frank I Lin, M.D. (1)  ·  Johar Raza, MD (1)  ·  Keno Bressem, MD (1)  ·  Klaus Wagner, MD, PhD (1)  ·  Nestor Esnaola, M.D. (1)

Results publications

PMID 41495369, PMID 41592385

NIH funding

2019 (1)